Prot# PXD101-301-G: A Phase II Clinical Trial of PXD101 In Patients with Advanced Multiple Myeloma

Project: Research project

Project Details

StatusFinished
Effective start/end date5/2/05 → 12/1/11

Funding

  • Prologue Research International, Inc. (PXD101-301-G)
  • CuraGen Corporation (PXD101-301-G)